BR112013005987A2 - composição farmacêutica estável em água, composição farmacêutica oral na forma líquida, processo para preparar uma composição farmacêutica estável em água, kit e composição de bebida de reidratação - Google Patents
composição farmacêutica estável em água, composição farmacêutica oral na forma líquida, processo para preparar uma composição farmacêutica estável em água, kit e composição de bebida de reidrataçãoInfo
- Publication number
- BR112013005987A2 BR112013005987A2 BR112013005987A BR112013005987A BR112013005987A2 BR 112013005987 A2 BR112013005987 A2 BR 112013005987A2 BR 112013005987 A BR112013005987 A BR 112013005987A BR 112013005987 A BR112013005987 A BR 112013005987A BR 112013005987 A2 BR112013005987 A2 BR 112013005987A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- water stable
- stable pharmaceutical
- composition
- kit
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 2
- 235000013361 beverage Nutrition 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Nanotechnology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38209810P | 2010-09-13 | 2010-09-13 | |
US13/231,150 US9018193B2 (en) | 2010-09-13 | 2011-09-13 | Aqueous drug delivery system |
PCT/US2011/051386 WO2012037117A1 (en) | 2010-09-13 | 2011-09-13 | Aqueous drug delivery system comprising off - flavor masking agent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013005987A2 true BR112013005987A2 (pt) | 2019-09-24 |
Family
ID=44674918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013005987A BR112013005987A2 (pt) | 2010-09-13 | 2011-09-13 | composição farmacêutica estável em água, composição farmacêutica oral na forma líquida, processo para preparar uma composição farmacêutica estável em água, kit e composição de bebida de reidratação |
Country Status (14)
Country | Link |
---|---|
US (4) | US9018193B2 (pt) |
EP (2) | EP3210597A1 (pt) |
JP (2) | JP5890951B2 (pt) |
KR (1) | KR20140007798A (pt) |
CN (1) | CN103209684A (pt) |
AU (1) | AU2011302293B2 (pt) |
BR (1) | BR112013005987A2 (pt) |
CA (1) | CA2811202A1 (pt) |
IL (1) | IL225149B (pt) |
MY (1) | MY162175A (pt) |
NZ (1) | NZ608239A (pt) |
RU (1) | RU2013116336A (pt) |
SG (2) | SG10201507554RA (pt) |
WO (1) | WO2012037117A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015175982A1 (en) * | 2014-05-16 | 2015-11-19 | Vivus, Inc. | Orally administrable formulations for the controlled release of a pharmacologically active agent |
US11623008B2 (en) * | 2014-08-20 | 2023-04-11 | Professional Compounding Centers Of America | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan |
WO2016092547A1 (en) * | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Alcoholic beverage substitutes |
WO2016092546A1 (en) | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Binge behavior regulators |
CN107406820B (zh) * | 2015-04-07 | 2021-06-15 | 日产化学工业株式会社 | 液态培养基组合物的制造方法、及用于该方法的制造装置和套件 |
US10493083B2 (en) | 2015-10-30 | 2019-12-03 | Cmp Development Llc | Spironolactone aqueous compositions |
US20210290524A1 (en) * | 2016-09-06 | 2021-09-23 | Children's Medical Center Corporation | Topical trpv1 antagonists and methods and compositions thereof |
MX2019002976A (es) * | 2016-09-16 | 2019-07-10 | Cydex Pharmaceuticals Inc | Formulaciones que contienen acetaminofén y sulfoalquil éter ciclodextrina. |
WO2019140403A1 (en) * | 2018-01-15 | 2019-07-18 | Seattle Gummy Company | Semi-solid anti-histamine compositions and methods of making and using thereof |
US10828286B2 (en) * | 2018-05-24 | 2020-11-10 | Gm Pharmaceuticals, Inc. | Niacin and berberine compositions and methods of use thereof |
CA3104568A1 (fr) * | 2018-06-29 | 2020-01-02 | Roquette Freres | Melange de molecules d'hydroxypropyl-.beta.-cyclodextrine et son procede de preparation |
JP2020019731A (ja) * | 2018-07-31 | 2020-02-06 | 日本食品化工株式会社 | アムロジピンベシル酸塩の苦味抑制剤 |
JP6711875B2 (ja) * | 2018-08-29 | 2020-06-17 | 日本食品化工株式会社 | マクロライド化合物の苦味抑制剤 |
US11452690B1 (en) * | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
GB9226391D0 (en) | 1992-12-18 | 1993-02-10 | Cpc International Inc | Xanthan gelling agents |
US5362860A (en) | 1993-02-01 | 1994-11-08 | Warner-Lambert Company | Neutral stabilization complex for CI-979 HCl, a cognition activator |
FR2704146B1 (fr) | 1993-04-19 | 1995-07-13 | Cripdom | Microcapsules d'acide acétylsalicylique à libération contrôlée. |
US5651980A (en) | 1994-04-15 | 1997-07-29 | Biohybrid Technologies, Inc. | Methods of use of uncoated gel particles |
US6319535B1 (en) | 1995-11-28 | 2001-11-20 | Laurence J. Shaw | Confections that “swim” in a carbonated beverage |
US6436461B1 (en) | 1996-10-09 | 2002-08-20 | Givauden Roure (International) Sa | Process for preparing gel beads as food additives |
CA2273206A1 (en) | 1996-11-29 | 1998-06-04 | Monsanto Company | Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
US5776431A (en) | 1997-03-26 | 1998-07-07 | Galat; Alexander | Water-soluble aspirin composition |
US7727552B1 (en) | 1997-03-28 | 2010-06-01 | Eisai R&D Management Co., Ltd. | Oral pharmaceutical preparations decreased in bitterness by masking |
BE1011251A3 (fr) | 1997-07-03 | 1999-06-01 | Ucb Sa | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine. |
EP1009410B1 (de) | 1997-07-15 | 2003-03-12 | Walter Burghart | Verfahren zum herstellen von stabilen acetylsalicylsäure-lösungen |
EP1027072A1 (en) | 1997-10-31 | 2000-08-16 | Monsanto Company | Controlled release compositions comprising gellan gum gels |
US6572898B2 (en) | 1999-05-21 | 2003-06-03 | Pts Labs Llc | Electrolyte gels for maintaining hydration and rehydration |
SK282717B6 (sk) | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
CN1476300B (zh) | 2000-10-16 | 2013-11-06 | 百事可乐公司 | 加钙饮料及其生产方法 |
US7141555B2 (en) | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
WO2003072141A1 (en) * | 2002-02-22 | 2003-09-04 | Pharmacia Corporation | Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride |
US20090215735A1 (en) * | 2002-02-25 | 2009-08-27 | Alcon, Inc. | Topical solution formulations containing a corticosteroid and a cyclodextrin |
AU2003211627A1 (en) | 2002-03-04 | 2003-09-16 | Medrx Co., Ltd. | Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
AU2003246489A1 (en) | 2002-07-19 | 2004-02-09 | Vitalstate Canada Ltd. | Oral delivery system containing a gel matrix and liposomes |
SI1553927T1 (sl) | 2002-09-11 | 2010-12-31 | Elan Pharma Int Ltd | Z gelom stabilizirani nanodeläśni sestavki uäśinkovine |
US20060018972A1 (en) | 2002-11-26 | 2006-01-26 | Upm Pharmaceuticals, Inc. | Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
US7160565B2 (en) | 2003-03-31 | 2007-01-09 | Breakthru Products, Llc | Hydration beverage and method of delivering nutrients |
JP4647493B2 (ja) | 2003-09-12 | 2011-03-09 | 株式会社龍角散 | 苦みマスキング粒状ゼリー飲料 |
US20070053939A1 (en) | 2003-10-17 | 2007-03-08 | Hideakira Yokoyama | Biguanide drug-containing jelly preparation |
IL160095A0 (en) | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
CA2547934C (en) * | 2004-02-19 | 2013-05-21 | Abbott Laboratories | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
CA2566793C (en) | 2004-05-11 | 2013-07-16 | Egalet A/S | A novel dosage form |
EP1750674A4 (en) | 2004-05-27 | 2012-05-23 | Advanced Bionutrition Corp | MICROPARTICLES FOR THE ORAL LEVY |
EP1771161B1 (en) | 2004-07-22 | 2010-04-21 | Bend Research, Inc | Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form |
US20070092561A1 (en) | 2005-06-24 | 2007-04-26 | Don Milne | Water-Soluble Aspirin Composition |
US8715731B2 (en) | 2006-03-22 | 2014-05-06 | Isp Investments Inc. | Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin |
PT103476B (pt) | 2006-05-10 | 2008-09-19 | Univ De Coimbra | Processo de produção e isolamento de micro- e nanopartículas poliméricas contendo macromoléculas de natureza hidrofílica e termolábil |
CN101588790A (zh) | 2006-07-06 | 2009-11-25 | 艾博特呼吸有限责任公司 | 超多孔水凝胶 |
US20100015227A1 (en) | 2006-07-14 | 2010-01-21 | Amos Nussinovitch | Dried electrified hydrocolloid gels having unique structure and porosity |
US20090304784A1 (en) | 2006-07-28 | 2009-12-10 | V. Mane Fils | Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
JP5205909B2 (ja) * | 2006-10-18 | 2013-06-05 | 大正製薬株式会社 | 粘膜適用液剤 |
JP5048398B2 (ja) * | 2007-06-13 | 2012-10-17 | 大蔵製薬株式会社 | 抗真菌剤の医薬組成物 |
US8974825B2 (en) | 2007-07-06 | 2015-03-10 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
KR100937625B1 (ko) | 2007-08-10 | 2010-01-20 | 주식회사 제닉 | 가용성 웹 공극필름 및 이의 제조방법 |
US9186640B2 (en) | 2007-08-28 | 2015-11-17 | Pepsico, Inc. | Delivery and controlled release of encapsulated lipophilic nutrients |
EP2211836A2 (en) * | 2007-10-10 | 2010-08-04 | Rubicon Research Private Limited | Taste-masked orally disintegrating tablets of memantine hydrochloride |
WO2009047859A1 (ja) | 2007-10-12 | 2009-04-16 | Ryukakusan Co. Ltd. | 薬服用粒状ゼリー飲料及びその製造方法 |
US20090104251A1 (en) | 2007-10-22 | 2009-04-23 | Sensient Flavors Inc. | Heat stable microcapsules and methods for making and using the same |
US8563066B2 (en) * | 2007-12-17 | 2013-10-22 | New World Pharmaceuticals, Llc | Sustained release of nutrients in vivo |
PL2609812T3 (pl) | 2007-12-20 | 2019-02-28 | N.V. Nutricia | Ciekły produkt zawierający nukleotydy/nukleozydy |
ES2402753T3 (es) | 2008-02-06 | 2013-05-08 | University Of East Anglia | Composición y método para ayudar a la deglución |
CN104491864A (zh) | 2008-04-21 | 2015-04-08 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物及方法 |
WO2009130704A1 (en) | 2008-04-24 | 2009-10-29 | Technion Research And Development Foundation Ltd. | Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
GB0813929D0 (en) | 2008-07-30 | 2008-09-03 | Glaxo Group Ltd | Novel method |
US9414615B2 (en) * | 2010-01-18 | 2016-08-16 | PepciCo, Inc. | Gel-based compositions and methods of making same |
-
2011
- 2011-09-13 CA CA2811202A patent/CA2811202A1/en not_active Abandoned
- 2011-09-13 NZ NZ608239A patent/NZ608239A/en not_active IP Right Cessation
- 2011-09-13 WO PCT/US2011/051386 patent/WO2012037117A1/en active Application Filing
- 2011-09-13 JP JP2013528384A patent/JP5890951B2/ja not_active Expired - Fee Related
- 2011-09-13 BR BR112013005987A patent/BR112013005987A2/pt not_active IP Right Cessation
- 2011-09-13 EP EP16186439.2A patent/EP3210597A1/en not_active Withdrawn
- 2011-09-13 AU AU2011302293A patent/AU2011302293B2/en not_active Ceased
- 2011-09-13 EP EP11760656.6A patent/EP2616046B1/en active Active
- 2011-09-13 US US13/231,150 patent/US9018193B2/en active Active
- 2011-09-13 MY MYPI2013700400A patent/MY162175A/en unknown
- 2011-09-13 SG SG10201507554RA patent/SG10201507554RA/en unknown
- 2011-09-13 SG SG2013017991A patent/SG188509A1/en unknown
- 2011-09-13 KR KR1020137009449A patent/KR20140007798A/ko not_active Application Discontinuation
- 2011-09-13 CN CN2011800546354A patent/CN103209684A/zh active Pending
- 2011-09-13 RU RU2013116336/15A patent/RU2013116336A/ru unknown
-
2013
- 2013-03-10 IL IL225149A patent/IL225149B/en not_active IP Right Cessation
-
2015
- 2015-03-30 US US14/672,337 patent/US9789191B2/en active Active
-
2016
- 2016-02-19 JP JP2016029886A patent/JP6263699B2/ja not_active Expired - Fee Related
-
2017
- 2017-10-17 US US15/786,217 patent/US20180256725A1/en not_active Abandoned
-
2019
- 2019-10-21 US US16/658,524 patent/US20200114011A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2012037117A1 (en) | 2012-03-22 |
SG10201507554RA (en) | 2015-10-29 |
EP3210597A1 (en) | 2017-08-30 |
AU2011302293B2 (en) | 2015-11-26 |
MY162175A (en) | 2017-05-31 |
IL225149B (en) | 2018-05-31 |
JP2013537891A (ja) | 2013-10-07 |
US20150209435A1 (en) | 2015-07-30 |
NZ608239A (en) | 2015-05-29 |
EP2616046A1 (en) | 2013-07-24 |
JP5890951B2 (ja) | 2016-03-22 |
CA2811202A1 (en) | 2012-03-22 |
US20120122823A1 (en) | 2012-05-17 |
SG188509A1 (en) | 2013-04-30 |
EP2616046B1 (en) | 2016-08-31 |
US9018193B2 (en) | 2015-04-28 |
AU2011302293A1 (en) | 2013-04-04 |
US9789191B2 (en) | 2017-10-17 |
JP2016153401A (ja) | 2016-08-25 |
JP6263699B2 (ja) | 2018-01-24 |
US20180256725A1 (en) | 2018-09-13 |
RU2013116336A (ru) | 2014-10-20 |
KR20140007798A (ko) | 2014-01-20 |
US20200114011A1 (en) | 2020-04-16 |
CN103209684A (zh) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013005987A2 (pt) | composição farmacêutica estável em água, composição farmacêutica oral na forma líquida, processo para preparar uma composição farmacêutica estável em água, kit e composição de bebida de reidratação | |
GB2490625B (en) | Improvements in and relating to bollards | |
BRPI0809674A2 (pt) | Formulação aquosa estéril, estável, forma de dosagem unitária farmacêutica, recipiente selado, kit, método para prevenir, controlar, tratar ou melhorar uma doença ou distúrbio inflamatório, composição, processo para a preparação de uma composição, e, método para estabilizar um anticorpo 13h5 | |
GB201109010D0 (en) | Improvements in and relating to bollards | |
BRPI0905717A2 (pt) | Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica | |
BR112013031658A2 (pt) | composição anidra na forma de creme | |
UY33106A (es) | Proceso para enmascarar rayaduras en recipiente de vidrio | |
EP2564830A4 (en) | AQUEOUS COMPOSITION CONTAINED IN A CONTAINER | |
BR112013003295A2 (pt) | recipiente de água para máquinas para preparar bebidas e máquina para preparar bebidas | |
BRPI0912161A2 (pt) | composição farmacêutica na forma de um tablete | |
CO6801754A2 (es) | Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida | |
HK1198115A1 (en) | Improvements in lockers | |
BRPI1007211A2 (pt) | composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição. | |
BRPI0925100A2 (pt) | forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica | |
BRPI0916319A2 (pt) | processo para a preparação de esomeprazol magnésico em uma forma estável | |
SG11201400599YA (en) | Cation exchange materials prepared in aqueous media | |
BRPI0815975A2 (pt) | Preparação aquosa, recipiente farmacêutico, processo para preparar uma preparação aquosa, e, uso de uma preparação aquosa | |
ZA201400718B (en) | Oral rehydration composition | |
HK1160343A2 (en) | Combined bottle in bamboo shape | |
BR112012000801A2 (pt) | recipiente para medicamento | |
BR112013025604A2 (pt) | uso de uma preparação na fabricação de uma composição nutricional líquida, composição nutricional líquida e uso da composição nutricional líquida | |
GB2493110B (en) | Improvements in and relating to bollards | |
GB201113347D0 (en) | Improvements in and relating to cementitious materials | |
ES1074117Y (es) | Estuche para botellas perfeccionado convertible en botellero apilable | |
TH127053B (th) | องค์ประกอบแอเควียสที่จะถูกบรรจุในภาชนะบรรจุ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |